St. Jude Photon Micro
This article was originally published in The Gray Sheet
Downsized dual-chamber (DR) and single-chamber (VR) implantable cardioverter defibrillators will be launched in July following FDA approval via premarket approval application supplement, announced June 19. The rate-adaptive, 32-joule devices, which have a volume of 37 cc and 36 cc, respectively, offer features similar to the previous generation Photon, which has a volume of 46 cc and debuted in the U.S. in October 2000...
You may also be interested in...
The Centers for Medicare & Medicaid Services is asking manufacturers to provide examples of medical technologies for which transitional "pass-through" payments might be appropriate even if the device itself does not provide an obvious improvement in beneficiary outcomes over existing technologies
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.